Market News How it works Learn FAQ
| RCT 0.132 73.46% | NU 12.36 -18.47% | EWZ 33.885 -20.44% | TGL 0.254 14.67% | SRTM 0.326 -24.24% | BBD 2.855 -29.85% | ITUB 7.6 -21.41% | AZTR 1.615 125.87% | SHFS 0.103 -22.21% | XP 15.575 -48.78% | GCDT 0.1361 -22.71% | CLRO 4.79 47.38% | SOXL 91.64 9.67% | SPCX 149.92 1.65% | NWGL 0.0829 1.10% | PBR 21.94 -16.13% | NVD 3.99 -4.77% | SGRY 23.0703 46.48% | TSLL 10.9599 12.29% | VALE 11.99 -3.31% | RBNE 0.1701 -10.47% | CRWV 57.4626 5.95% | INTC 90.785 4.40% | NVDA 216.2072 2.49% | SOXS 47.41 -9.63% | BITO 10.77 -0.55% | ABEV 2.8 -15.15% | IREN 26.5486 6.60% | JBLU 2.295 -12.57% | NOK 8.625 5.96% | XTND 2.2 24.29% | SPRC 1.5001 37.62% | GPUS 0.1782 5.51% | TQQQ 69.14 4.30% | SBS 4.765 -25.55% | INTR 4.6286 -35.62% | TSLG 5.48 12.53% | RWM 14.435 -0.79% | TSLA 395.443 6.24% | SPDN 8.475 -0.76% | SQQQ 37.975 -4.30% | AAL 12.2055 0.79% | SID 0.9269 -21.45% | GGB 4.765 -6.57% | PBR-A 19.3388 -17.81% | RENT 2.9015 26.15% | LUCD 0.5155 25.43% | CIFR 8.1475 2.61% | KORU 10.9537 3.53% | WULF 12.08 6.71%
AWAspira Women's Health Inc. logo

Aspira Women's Health Inc. (AWH)

NASDAQ Capital Market · Currency in USD
$0.08 ▼ -0.02 (-15.90%)
As of Feb 10, 4:00 PM ET. Market open.

Summary

Previous Close
$0.10
Open
$0.08
Day's Range
$0.08 – $0.08
52 Week Range
$0.08 – $3.63
Volume
443,521
Avg. Volume
4,524,051
Market Cap
$2.46M
Beta (5Y Monthly)
2.01
PE Ratio (TTM)
--
EPS (TTM)
-$0.23
Earnings Date
--
Forward Dividend & Yield
$0.07 (84.39%)
Ex-Dividend Date
Dec 16, 2016
1y Target Est
$3.30

Profile: Aspira Women's Health Inc.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
66
CEO
Nicolette Possemato

Aspira Women's Health Inc., alongside its subsidiaries, specializes in the development and commercialization of diagnostic tools for gynecologic diseases across the United States. Their product portfolio includes tests such as OVA1, OVERA, and OVA1plus, designed to evaluate the risk of ovarian malignancy in women presenting with adnexal masses. Additionally, they provide ASPiRA GenetiX, a genetic screening option for assessing individual susceptibility to gynecologic cancers.

Earnings

DateEst.Actual
Nov 12, 2025–-$0.13
Aug 11, 2025–-$0.07
May 13, 2025-$0.15-$8.58Miss
Mar 27, 2025-$0.22-$0.08Beat
Nov 19, 2024-$0.24-$0.23Beat
Aug 12, 2024-$0.32-$0.28Beat

Analyst view

Consensus price target
$3.30 ▲ +3,924.4%
Range $3.30 – $3.30
Rating: Buy
Buy 60% · Hold 40% · Sell 0%

Get free alerts on AWH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.